Dominant Oncogenes and Tumor Suppressor Genes in the Pathogenesis of Lung Cancer
- 1 March 1990
- journal article
- review article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 2 (3) , 225-232
- https://doi.org/10.1165/ajrcmb/2.3.225
Abstract
An understanding of the molecular pathogenesis of lung cancer has evolved from classic cytogenetic studies and the use of restriction fragment length polymorphisms to encompass the definition of specific genetic abnormalities associated with this disease. Activation of the dominant class of oncogenes is frequent, with involvement of the ras and myc families of genes being the best defined. Several examples of inactivation at specific loci exist and have been related to the presence of tumor suppressor genes, most notably the retinoblastoma gene, p53, and a putative gene located on the short arm of chromosome 3. As our understanding of the nature and interactions between these numerous genetic events evolves, new opportunities for early diagnosis, prevention, and treatment will arise.Keywords
This publication has 67 references indexed in Scilit:
- Gastrin-releasing peptide (GRP, mammalian bombesin) in the pathogenesis of lung cancerProgress in Growth Factor Research, 1989
- AP1, a composite transcription factor implictted in abnormal growth controlProgress in Growth Factor Research, 1989
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Insertion of the v-Ha-ras oncogene induces differentiation of calcitonin-producing human small cell lung cancer.Journal of Clinical Investigation, 1989
- Role of raf oncogenes in lung carcinogenesisLung Cancer, 1988
- Correlation of DNA adduct levels in human lung with cigarette smokingNature, 1988
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988
- Molecular Analysis of the Short Arm of Chromosome 3 in Small-Cell and Non-Small-Cell Carcinoma of the LungNew England Journal of Medicine, 1987
- myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course.Journal of Clinical Investigation, 1987
- c-K-ras codon 12 GGT-CGT point mutation an infrequent event in human lung cancerBiochemical and Biophysical Research Communications, 1986